​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​APHL in Action delivers a quarterly update on association activities to members and 450+ senior decision makers at federal agencies and nonprofits. To be added to the mailing list, please send an email to Brittany Robertson​, specialist, Communications.

Current Issue  Current Issue

Summer 2024

  • 7 Public Health Lab Professionals Describe Why They Started in Lab Science—and What Makes Them Stay
    Preparing specimens. Identifying pathogens. Detecting outbreaks. Working in a public health laboratory isn’t always pretty, but according to the lab professionals we talked with, it is incredibly important and rewarding.

  • APHL Partners with Chan Zuckerberg Initiative to Bring Genomics Training to Regional Hubs
    The Chan Zuckerberg Initiative (CZI) has partnered with APHL’s Global Health team to bring genomic epidemiologic training to regions around the world via the Chan Zuckerberg Biohub Network (CZBiohub Network). CZBiohub Network is a group of nonprofit research institutes supported by CZI that bring together scientists, engineers and physicians with the goal of pursuing grand scientific challenges on 10- to 15-year time horizons. It focuses on understanding underlying mechanisms of disease and developing new technologies that will lead to actionable diagnostics and effective therapies.

  • How the antiscience movement has risen in America—and where it’s headed next
    The COVID-19 pandemic didn’t launch the antiscience, antivax movement in this country, but it certainly escalated it. And with deadly effects. Peter Hotez, MD, PhD, co-director of Texas Children’s Hospital Center for Vaccine Development and the Dr. Katherine Kelley Distinguished Lecture speaker at APHL’s 2024 Annual Conference, outlined the rise of antiscience activism in this country, the politicization of the movement and the dire consequences it continues to produce.

  • Eyes Below the Surface: Wastewater Surveillance Pilot Program in Uganda Shows Potential for Future Pandemic Monitoring
    On March 21, 2020, Uganda declared their first confirmed case of COVID-19. As of July 14, 2023, a total of 168,489 cases and 3,627 deaths had been reported in the country. Initially, prevalence estimates of COVID-19 in Uganda were strictly limited to clinical surveillance – cases diagnosed following a doctor or hospital visit. In coordination with the Global Fund, the Uganda Central Public Health Laboratories (CPHL) and the National Water and Sewage Corporation, APHL launched a pilot program to explore the feasibility of using wastewater-based epidemiology to monitor the COVID-19 rates in the country.

  • As Gonorrhea Cases Mount, Treatment Options Dwindle
    Nearly 650,000 cases of gonorrhea were reported in the U.S. in 2022, making it the second-most commonly notifiable sexually transmitted disease (STD) in this country. Chlamydia takes the number-one spot. But it’s not just the number of gonorrhea cases that has public health officials alarmed—it’s the propensity of the organism to become resistant to the drugs that can effectively treat it.
Read the Full Is​sue​​​ ​​

Previous Issues  Previous Issues

Spring 2024

Read the Full Is​sue

Fall 2023

Summer 2023

Read the Full Is​sue

Spring 2023

Read the Full Issue

Fall 2022

Read the Full Issue ​​​

Summer 2022

Read the Full Issue

Winter 2022

Read the Full Issue

Fall 2021

Read the Full Issue

Spring 2021

Read the Full Issue

Winter 2021

Read the Full Issue​​​

Summer 2020

Read the Full Issue​​​ ​

Spring 2020

Read the Full Issue

Fall 2019

Read the Full Issue

Summer 2019

Read the Full Issue

Spring 2019

Read the Full Issue

 Winter 2019

Read the Full Issue

Summer 2018

Spring 2018

Winter 2018

Fall 2017

Summer 2017

​Spring 2017

Winter 2017

Fall 2016

Summer 2016

​Spring 2016

Winter 2016

Fall 2015

 Summer 2015

Spring 2015

Winter 2015